circ_0000515 promotes invasion and migration of breast cancer by attenuating MDM2-mediated FUS ubiquitination and degradation

Author:

Liu Xiaofeng1,Chen Wenyan1,Qi Yu1,Zhu Yongqian1

Affiliation:

1. Traditional Chinese Medicine Hospital of LuAn

Abstract

Abstract Background: Breast cancer (BC) is the second lethal cancer with the highest and rising morbidity in females. Emerging evidences have illustrated that circular RNAs (circRNAs) play essential roles in the tumorigenesis and metastasis of BC. However, the specific functions and underlying mechanistic involvement of circ_0000515 in BC have not yet been explored. Methods: Three BC datasets (GES101123, GES165884, and GES182471) from the NCBI GEO database were screened to identify differentially expressed circRNAs (DEcircRNAs). Then transwell and wound healing assays were performed to determinethe function of circ_0000515 in BC. The identification of downstream targets of circ_0000515 was performed using bioinformatics methods. RNA-pulldown assays, RIP assay, and CO-IP were further employed to identify the critical signaling pathway regulated by circ_0000515. Finally, rescue experiments were employed to confirm the connection between circ_0000515 and FUS in BC metastasis. Results: Circ_0000515 of a total of 49 DEcircRNAs was identified in BC datasets. Interestingly, the abundance of circ_0000515 was significantly increased in BC cells. Loss-of-functional experiments in vitro showed silencing circ_0000515 inhibited the invasion, migration and EMT process of BC. Mechanically, circ_0000515 stabilized the expression of FUS by impeding the interplay between FUS and MDM2, thereby protecting FUS from proteasomal degradation. Interestingly, we identified that FUS knockdown dramatically alleviated the promotive effect of circ_0000515 on BC metastasis. Conclusion: Circ_0000515 promoted invasion and migration of BC by attenuating MDM2-mediated FUS ubiquitination and degradation, and might function as a biomarker and therapeutic target for BC.

Publisher

Research Square Platform LLC

Reference33 articles.

1. Cancer statistics, 2022";Siegel RL;CA Cancer J Clin,2022

2. U. Veronesi, P. Boyle, A. Goldhirsch, et al., "Breast cancer", Lancet, vol. 365, no. 9472, pp. 1727–1741, 2005.

3. N. Harbeck and M. Gnant, "Breast cancer", Lancet, vol. 389, no. 10074, pp. 1134–1150, 2017.

4. Breast Cancer: Current Perspectives on the Disease Status";Fahad Ullah M;Adv Exp Med Biol,2019

5. Breast cancer: Staying silent";Harjes U;Nat Rev Cancer,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3